The University of Florida (UF) Division of Sponsored Research was awarded a $589,591 Project Grant from the National Cancer Institute (NCI) under the 21st Century Cures Act - Beau Biden Cancer Moonshot program (CFDA 93.353). The grant, awarded on February 1, 2025, will fund a 5-year study to identify barriers leading to inferior survival rates for Black and Hispanic patients with Hodgkin lymphoma.
The research will involve a mixed-methods approach, including analyzing longitudinal electronic medical record and claims data from the Patient-Centered Outcomes Research Network (PCORNET) and the Center for International Blood and Marrow Transplant Research (CIBMTR) to examine differences in Hodgkin lymphoma treatment and survivorship care. Additionally, in-depth interviews will be conducted with a sample of Hodgkin lymphoma survivors and caregivers, with a focus on understanding the treatment and survivorship decision-making process for patients from diverse racial and ethnic backgrounds. The goal of this innovative research is to provide evidence-based insights to inform policies and interventions aimed at addressing healthcare inequities and improving outcomes for Black and Hispanic Hodgkin lymphoma survivors.
Generated 3/4/25, 5:03 AM